Leukocyte-rich vs. leukocyte-poor platelet-rich plasma for the treatment of knee osteoarthritis

HIGHLIGHTS

  • who: Ashim Gupta and collaborators from the Italy Italy have published the research work: Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis, in the Journal: Biomedicines 2023, 11, 141. of 29/Dec/2022
  • what: The authors focus on the presence of leukocytes, a highly discussed attribute related to the efficacy of PRP and a key discriminant in differentiating PRP formulations. The survey examines three categories: symptoms, sport activity and knee function.

SUMMARY

    Presently, knee OA is managed through traditional treatment modalities, including pharmacological methods such . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?